Evidence map›Paper›PMID 10024562›Full record

ArticleInfection and immunity1999

The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: implications for the pathogenesis of cystic fibrosis lung disease.

B E Britigan, M A Railsback, C D Cox

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Bacterial Biofilm Control by Perturbation of Bacterial Signaling Processes.International journal of molecular sciences · 2017
    Review
  16. Review
  17. Article
  18. Functional amyloids keep quorum-sensing molecules in check.The Journal of biological chemistry · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

B E BritiganMedical Service, VA Medical Center, Iowa City, Iowa 52246, USA. bradley-britigan@mail.int-med.uiowa.edu
M A Railsback
C D Cox
Iowa City VA Medical Center · USUniversity of Iowa · US

Funding

PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURYR01AI034954 · NIAID · UNIVERSITY OF IOWA · PI BRITIGAN, BRADLEY E · 1994 to 2003
$941k
MONOCYTE/MACROPHAGE FREE RADICAL BIOLOGY ASSESSED BY EPRR29HL044275 · NHLBI · UNIVERSITY OF IOWA · PI BRITIGAN, BRADLEY E · 1989 to 1993
–
NHLBI NIH HHS HL44275NIAID NIH HHS AI34954
6 · The paper itself

Abstract

Alpha1 Protease inhibitor (alpha1PI) modulates serine protease activity in the lung. Reactive oxygen species inactivate alpha1PI, and this process has been implicated in the pathogenesis of a variety of forms of lung injury. An imbalance of protease-antiprotease activity is also detected in the airways of patients with cystic fibrosis-associated lung disease who are infected with Pseudomonas aeruginosa. P. aeruginosa secretes pyocyanin, which, through its ability to redox cycle, induces cells to generate reactive oxygen species. We tested the hypothesis that redox cycling of pyocyanin could lead to inactivation of alpha1PI. When alpha1PI was exposed to NADH and pyocyanin, a combination that results in superoxide production, alpha1PI lost its ability to form an inhibitory complex with both porcine pancreatic elastase (PPE) and trypsin. Similarly, addition of pyocyanin to cultures of human airway epithelial cells to which alpha1PI was also added resulted in a loss of the ability of alpha1PI to form a complex with PPE or trypsin. Neither superoxide dismutase, catalase, nor dimethylthiourea nor depletion of the media of O2 to prevent formation of reactive oxygen species blocked pyocyanin-mediated inactivation of alpha1PI. These data raise the possibility that a direct interaction between reduced pyocyanin and alpha1PI is involved in the process. Consistent with this possibility, pretreatment of alpha1PI with the reducing agent beta-mercaptoethanol also inhibited binding of trypsin to alpha1PI. These data suggest that pyocyanin could contribute to lung injury in the P. aeruginosa-infected airway of cystic fibrosis patients by decreasing the ability of alpha1PI to control the local activity of serine proteases.

Indexed as

alpha 1-AntitrypsinCystic FibrosisHumansLung DiseasesNADOxidation-ReductionPseudomonas aeruginosaPyocyanineReactive Oxygen SpeciesSuperoxidesTumor Cells, Culturedalpha 1-AntitrypsinNADPyocyanineReactive Oxygen SpeciesSuperoxides

Identifiers

PMID10024562
PMCPMC96448
OpenAlexW2144067348

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.